Evidence map›Paper›PMID 30190529›Full record

ArticleScientific reports2018

Differences in antigenic sites and other functional regions between genotype A and G mumps virus surface proteins.

Sigrid Gouma, Tessa Vermeire, Steven Van Gucht, Lennart Martens, Veronik Hutse, Jeroen Cremer, Paul A Rota, Geert Leroux-Roels, Marion Koopmans, Rob van Binnendijk and 1 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Development of a Novel mRNA Vaccine AgainstBioinformatics and biology insights · 2025
    Article
  7. Alveolar macrophages are early targets of mumps virus.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  8. Article
  9. Article
  10. Disentangling the causes of mumps reemergence in the United States.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Sigrid GoumaCentre for Infectious Disease Control, RIVM, Bilthoven, The Netherlands.
Tessa VermeireNational Reference Centre for Measles, Mumps and Rubella, Sciensano, Brussels, Belgium.
Steven Van GuchtNational Reference Centre for Measles, Mumps and Rubella, Sciensano, Brussels, Belgium. steven.vangucht@sciensano.be.ORCID http://orcid.org/0000-0002-8150-9372
Lennart MartensDepartment of Biochemistry, Ghent University, Ghent, Belgium.
Veronik HutseNational Reference Centre for Measles, Mumps and Rubella, Sciensano, Brussels, Belgium.
Jeroen CremerCentre for Infectious Disease Control, RIVM, Bilthoven, The Netherlands.
Paul A RotaNational Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, USA.
Geert Leroux-RoelsCenter for Vaccinology, Ghent University, Ghent, Belgium.
Marion KoopmansCentre for Infectious Disease Control, RIVM, Bilthoven, The Netherlands.
Rob van BinnendijkCentre for Infectious Disease Control, RIVM, Bilthoven, The Netherlands.
Elien VandermarliereDepartment of Biochemistry, Ghent University, Ghent, Belgium.
Ghent University · BEErasmus MC · NLSciensano (Belgium) · BECenters for Disease Control and Prevention · USGhent University Hospital · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The surface proteins of the mumps virus, the fusion protein (F) and haemagglutinin-neuraminidase (HN), are key factors in mumps pathogenesis and are important targets for the immune response during mumps virus infection. We compared the predicted amino acid sequences of the F and HN genes from Dutch mumps virus samples from the pre-vaccine era (1957-1982) with mumps virus genotype G strains (from 2004 onwards). Genotype G is the most frequently detected mumps genotype in recent outbreaks in vaccinated communities, especially in Western Europe, the USA and Japan. Amino acid differences between the Jeryl Lynn vaccine strains (genotype A) and genotype G strains were predominantly located in known B-cell epitopes and in N-linked glycosylation sites on the HN protein. There were eight variable amino acid positions specific to genotype A or genotype G sequences in five known B-cell epitopes of the HN protein. These differences may account for the reported antigenic differences between Jeryl Lynn and genotype G strains. We also found amino acid differences in and near sites on the HN protein that have been reported to play a role in mumps virus pathogenesis. These differences may contribute to the occurrence of genotype G outbreaks in vaccinated communities.

Indexed as

GenotypeGlycosylationHN ProteinHumansMembrane ProteinsMumpsMumps VaccineMumps virusHN ProteinMembrane ProteinsMumps Vaccine

Identifiers

PMID30190529
PMCPMC6127219
OpenAlexW2888949768

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.